Imbalances in the gut microbiota abundance may affect the release of neurotransmitters and inflammatory mediators, such as glutamate, calcitonin gene-related peptide, and interleukin (IL)-1β, which might increase the risk of migraine (Arzani et al., 2020; Crawford et al., 2022). The gene discussed is IL1B; the disease is migraine disorder.